A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)
Titel:
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)
Auteur:
Phillips, Tycel J. Avigdor, Abraham Gurion, Ronit Patti, Caterina Corradini, Paolo Tani, Monica Mehta, Amitkumar Lossos, Izidore S. Zinzani, Pier Luigi Thieblemont, Catherine Jurczak, Wojciech Zheng, Fred Rappold, Erica Zhao, Wanying Jiang, Ping Johnson, Peter